Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
Open Access
- 24 January 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 16 (2), 214-218
- https://doi.org/10.1038/nm.2090
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast CancerCancer Cell, 2009
- A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancerNature Medicine, 2009
- A strategy for predicting the chemosensitivity of human cancers and its application to drug discoveryProceedings of the National Academy of Sciences of the United States of America, 2007
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell, 2006
- Genomic signatures to guide the use of chemotherapeuticsNature Medicine, 2006
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimationStatistics in Medicine, 2004
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerThe New England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002